Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Kunz, Cornelia Ursula [VerfasserIn]   i
 Kieser, Meinhard [VerfasserIn]   i
Titel:Estimation of secondary endpoints in two-stage phase II oncology trials
Verf.angabe:Cornelia Ursula Kunz and Meinhard Kieser
E-Jahr:2012
Jahr:30 December 2012
Umfang:17 S.
Fussnoten:Gesehen am 06.11.2018 ; Special Issue: Papers from the 32nd Annual Conference of the International Society for Clinical Biostatistics
Titel Quelle:Enthalten in: Statistics in medicine
Ort Quelle:Chichester [u.a.] : Wiley, 1982
Jahr Quelle:2012
Band/Heft Quelle:31(2012), 30, Seite 4352-4368
ISSN Quelle:1097-0258
Abstract:In the development of a new treatment in oncology, phase II trials play a key role. On the basis of the data obtained during phase II, it is decided whether the treatment should be studied further. Therefore, the decision to be made on the basis of the data of a phase II trial must be as accurate as possible. For ethical and economic reasons, phase II trials are usually performed with a planned interim analysis. Furthermore, the decision about stopping or continuing the study is usually based on a short-term outcome like tumor response, whereas secondary endpoints comprise stable disease, progressive disease, toxicity, and/or overall survival. The data obtained in a phase II trial are often analyzed and interpreted by applying the maximum likelihood estimator (MLE) without taking into account the sequential nature of the trial. However, this approach provides biased results and may therefore lead to wrong conclusions. Whereas unbiased estimators for two-stage designs have been derived for the primary endpoint, such estimators are currently not available for secondary endpoints. We present uniformly minimum variance unbiased estimators (UMVUE) for secondary endpoints in two-stage designs that allow stopping for futility (and efficacy). We compare the mean squared error of the UMVUE and the MLE and investigate the efficiency of the UMVUE. A clinical trial example illustrates the application.
DOI:doi:10.1002/sim.5585
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: http://dx.doi.org/10.1002/sim.5585
 Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/sim.5585
 DOI: https://doi.org/10.1002/sim.5585
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:clinical trial
 phase II
 secondary endpoint
 two-stage
 unbiased estimator
K10plus-PPN:1582594996
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68325148   QR-Code
zum Seitenanfang